Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China flag China · Delayed Price · Currency is CNY
33.78
-0.27 (-0.79%)
Feb 13, 2026, 3:00 PM CST

SHA:688076 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
988.01571.39749.08399.96591.8869.71
Trading Asset Securities
93208-43.0187.1380
Cash & Short-Term Investments
1,081779.39749.08442.98679.01149.71
Cash Growth
63.41%4.05%69.10%-34.76%353.54%157.70%
Accounts Receivable
687.5539.21297.26251.29143.37109.12
Other Receivables
8.317.923.271.191.055.05
Receivables
695.81547.13300.53252.48144.41114.17
Inventory
841.07584.04377.17323.48250.82185
Other Current Assets
126.4894.9767.9833.5329.8639.03
Total Current Assets
2,7442,0061,4951,0521,104487.91
Property, Plant & Equipment
2,5851,8921,405988.47706.55613.74
Long-Term Investments
241.53215.04117.594.5--
Goodwill
156.34156.34156.34156.34160.92162.2
Other Intangible Assets
174.13108.19112.198.1888.5787.11
Long-Term Deferred Tax Assets
119.6888.2746.6528.1316.6326.5
Long-Term Deferred Charges
310.57203.241.0338.7715.6612.02
Other Long-Term Assets
358.52409.4173.8465.4434.466.11
Total Assets
6,6905,0783,5472,5222,1271,396
Accounts Payable
596.6159.7141.9387.6172.3624.49
Accrued Expenses
54.81149.1286.1448.4943.9932.98
Short-Term Debt
1,1401,044546.02318.7377.27177.95
Current Portion of Long-Term Debt
183.2117.8940.08--32
Current Portion of Leases
-9.795.291.473.64-
Current Income Taxes Payable
18.3619.3511.475.37-12.85
Current Unearned Revenue
27.2761.218.396.8526.1713.34
Other Current Liabilities
30.66191.83134.0182.851.9688.6
Total Current Liabilities
2,0511,753973.34551.32275.4382.21
Long-Term Debt
1,228445.21286.49--37.95
Long-Term Leases
32.925.7517.18-2.74-
Long-Term Unearned Revenue
146.2455.9931.4635.3221.744.4
Long-Term Deferred Tax Liabilities
7.988.6110.1610.774.264.99
Other Long-Term Liabilities
90.25107.4339.31-14-
Total Liabilities
3,5562,3961,358597.41318.14429.55
Common Stock
316.05219.78213.18213.18213.18159.89
Additional Paid-In Capital
1,7541,5981,3411,3191,318641.03
Retained Earnings
1,057792.51495.37374.95277.82162.43
Comprehensive Income & Other
-17.9250.11120.233.332.2-
Total Common Equity
3,1092,6602,1701,9101,811963.34
Minority Interest
24.8621.9519.0414.66-2.612.68
Shareholders' Equity
3,1342,6822,1891,9251,809966.02
Total Liabilities & Equity
6,6905,0783,5472,5222,1271,396
Total Debt
2,5841,642895.07320.1983.65247.89
Net Cash (Debt)
-1,503-863.06-145.98122.79595.36-98.18
Net Cash Growth
----79.38%--
Net Cash Per Share
-4.86-2.81-0.490.412.21-0.44
Filing Date Shares Outstanding
316.05307.69298.46298.46298.46223.84
Total Common Shares Outstanding
316.05307.69298.46298.46298.46223.84
Working Capital
693.33252.82521.43501.15828.71105.7
Book Value Per Share
9.848.657.276.406.074.30
Tangible Book Value
2,7792,3961,9021,6561,562714.04
Tangible Book Value Per Share
8.797.796.375.555.233.19
Buildings
-516.19504.29476.24376.08339.12
Machinery
-1,6031,123652.13529435.18
Construction In Progress
-339.92185.96180.1134.859.88
Source: S&P Global Market Intelligence. Standard template. Financial Sources.